A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis-Reference-Cited by-同舟云学术

A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

Published:2011-04 Issue:4 Volume:12 Page:377-386
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Paranjape Trupti,Heneghan Helen,Lindner Robert,Keane Florence K,Hoffman Aaron,Hollestelle Antoinette,Dorairaj Jemima,Geyda Kimberly,Pelletier Cory,Nallur Sunitha,Martens John WM,Hooning Maartje J,Kerin Michael,Zelterman Daniel,Zhu Yong,Tuck David,Harris Lyndsay,Miller Nicola,Slack Frank,Weidhaas Joanne

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci USA,2001

2. Locoregional relapse and distant metastasis in conservatively managed triple-negative early-stage breast cancer;Haffty;J Clin Oncol,2006

3. Triple-negative/basal-like breast cancer: review;Rakha;Pathology,2009

4. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers;Lim;Nat Med,2009

5. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer;Bild;Breast Cancer Res,2009

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436;Breast Cancer Research and Treatment;2024-06-19

2. Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4BG13D/PDE6δ complex;Frontiers in Oncology;2024-03-20

3. Functional pri-miR-34b/c rs4938723 and KRAS 3′UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome?;Gene;2024-03

4. The effects of miR-217 inhibitor and mimic in the progression of Kirsten rat sarcoma viral oncogene homologue driven cancers;Medical Journal Armed Forces India;2024-03

5. The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC;Cancer Research Communications;2023-10-11